Trexquant Investment LP Adaptive Biotechnologies Corp Transaction History

Trexquant Investment LP

  • $7.59 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$6.26 - $9.34 $676,912 - $1.01 Million
108,133 Added 688.39%
123,841 $946,000
Q3 2022

Nov 14, 2022
BUY
$6.5 - $12.67 $102,102 - $199,020
15,708 New
15,708 $112,000
Q4 2021

Feb 14, 2022
SELL
$25.17 - $36.85 $251,423 - $368,094
-9,989 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$30.02 - $39.87 $299,869 - $398,261
9,989 New
9,989 $340,000

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email